(Q40467575)

20 September 2017

1 reference

title

Drugs on the horizon for treatment of type 2 diabetes. (English)

1 reference

20 September 2017

1 reference

Rachman J

1

1 reference

PubMed ID

7648818

20 September 2017

Turner RC

series ordinal

2

1 reference

20 September 2017

1 June 1995

1 reference

20 September 2017

1 reference

20 September 2017

12

1 reference

20 September 2017

6

1 reference

20 September 2017

467-478

1 reference

Lilly lecture 1987. The triumvirate: beta-cell, muscle, liver. A collusion responsible for NIDDM.

20 September 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.1995.TB00526.X

Slow glucose removal rate and hyperinsulinemia precede the development of type II diabetes in the offspring of diabetic parents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.1995.TB00526.X

New oral thiazolidinedione antidiabetic agents act as insulin sensitizers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.1995.TB00526.X

Effects of alpha-adrenoceptor antagonists on clonidine-induced inhibition of insulin secretion by isolated pancreatic islets

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.1995.TB00526.X

Adrenergic regulation of insulin secretion during fasting in normal subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.1995.TB00526.X

Imidazoline antagonists of alpha 2-adrenoceptors increase insulin release in vitro by inhibiting ATP-sensitive K+ channels in pancreatic beta-cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.1995.TB00526.X

Effect of acarbose on carbohydrate and lipid metabolism in NIDDM patients poorly controlled by sulfonylureas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.1995.TB00526.X

The efficacy of acarbose in the treatment of patients with non-insulin-dependent diabetes mellitus. A multicenter controlled clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.1995.TB00526.X

Mechanism(s) of the blood glucose lowering action of benfluorex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.1995.TB00526.X

Benfluorex and blood glucose control in non insulin-dependent diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.1995.TB00526.X

10.1111/J.1464-5491.1995.TB00526.X

21 January 2018

Identifiers

DOI

1 reference

20 September 2017

1 reference

PubMed ID

7648818